These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16420226)

  • 1. Anticoagulation of atrial fibrillation in older people: a clinical practice observational study.
    Abdelhafiz AH; Wheeldon NM
    J Am Geriatr Soc; 2006 Jan; 54(1):176-7. PubMed ID: 16420226
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulation for atrial fibrillation patients with CHADS score of 1.
    Lane DA; Lip GY
    J Cardiovasc Electrophysiol; 2010 May; 21(5):508-10. PubMed ID: 20082649
    [No Abstract]   [Full Text] [Related]  

  • 3. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
    Abdelhafiz AH; Wheeldon NM
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thromboembolism in non-rheumatic atrial fibrillation].
    Pengo V
    Haematologica; 2001 Sep; 86(9 Suppl):5-11. PubMed ID: 11759619
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care.
    Nichol MB; Knight TK; Dow T; Wygant G; Borok G; Hauch O; O'Connor R
    Ann Pharmacother; 2008 Jan; 42(1):62-70. PubMed ID: 18094348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation control in atrial fibrillation patients present to outpatient clinic of cardiology versus anticoagulant clinics.
    Du X; Ma CS; Liu XH; Dong JZ; Wang JN; Cheng XJ
    Chin Med J (Engl); 2005 Jul; 118(14):1206-9. PubMed ID: 16117867
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral anticoagulation in patients aged 75 years or older with chronic non-valvar atrial fibrillation: effectiveness and safety in daily clinical practice.
    Ruiz Ortiz M; Romo Peñas E; Franco Zapata MF; Mesa Rubio D; Anguita Sánchez M; López Granados A; Arizón del Prado JM; Vallés Belsué F
    Heart; 2005 Sep; 91(9):1225-6. PubMed ID: 16103572
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse.
    Wyse DG
    Circulation; 2007 May; 115(21):2684-6. PubMed ID: 17533193
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis.
    Heidinger KS; Bernardo A; Taborski U; Müller-Berghaus G
    Thromb Res; 2000 May; 98(4):287-93. PubMed ID: 10822075
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality of oral anticoagulation in patients with atrial fibrillation: a cross-sectional study in general practice.
    Neree C
    Eur J Gen Pract; 2006; 12(4):163-8. PubMed ID: 17127602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.
    Boulanger L; Hauch O; Friedman M; Foster T; Dixon D; Wygant G; Menzin J
    Ann Pharmacother; 2006 Jun; 40(6):1024-9. PubMed ID: 16735649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 20. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.